España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Novavax
NVAX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.81
0.41
4.88%
At close: -
$8.82
0.01000
0.11%
After Hours: 7:49 PM EDT
Get Report
Comment
Novavax (NVAX) Forecast
News
Earnings
Novavax (NVAX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Novavax (NASDAQ:NVAX) Stock
Novavax Stock (NASDAQ: NVAX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 21, 2025
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
Erica Kollmann
Thursday, January 16, 2025
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
Erica Kollmann
'As Bird Flu Affects More People And Animals,...
Benzinga Newsdesk
Monday, January 13, 2025
Looking Into Novavax's Recent Short Interest
Benzinga Insights
Why Novavax (NVAX) Stock Is Falling
Henry Khederian
Shares of vaccine stocks are trading lower af...
Benzinga Newsdesk
Thursday, January 09, 2025
Why Novavax Stock Is Volatile This Week
Henry Khederian
Wednesday, January 08, 2025
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Chandrima Sanyal
Tuesday, January 07, 2025
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Erica Kollmann
Shares of vaccine makers are trading higher a...
Benzinga Newsdesk
Why Novavax (NVAX) Stock Is Rising
Henry Khederian
Shares of vaccine makers are trading higher a...
Benzinga Newsdesk
Monday, January 06, 2025
'LDH Reports First U.S. H5N1-Related Human De...
Benzinga Newsdesk
Friday, December 20, 2024
Peering Into Novavax's Recent Short Interest
Benzinga Insights
Wednesday, December 18, 2024
CA Governor Newsom Proclaimed State Of Emerge...
Benzinga Newsdesk
CDC Confirms First Severe Case Of H5N1 Bird F...
Benzinga Newsdesk
Friday, December 13, 2024
Novavax Advances Corporate Growth Strategy Th...
Benzinga Newsdesk
Tuesday, December 10, 2024
HC Wainwright & Co. Reiterates Buy on Novavax...
Benzinga Newsdesk
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Avi Kapoor
Novavax Initiates Phase 3 Trial For COVID-19-...
Benzinga Newsdesk
Saturday, December 07, 2024
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Anthony Noto
Friday, December 06, 2024
Reuters Agriculture & Energy Policy Reporter ...
Benzinga Newsdesk
Wednesday, December 04, 2024
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Vandana Singh
Novavax Sells Czech Republic Manufacturing Fa...
Benzinga Newsdesk
Thursday, November 21, 2024
Watching Shares Of Vaccine Stocks; Traders Ci...
Benzinga Newsdesk
Wednesday, November 20, 2024
U.S. CDC Says Flu, Covid-19, RSV Illnesses Ar...
Benzinga Newsdesk
Monday, November 18, 2024
U.S. CDC Says Since April Confirmed Avian Inf...
Benzinga Newsdesk
Friday, November 15, 2024
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
The Arora Report
Shares of vaccine stocks are trading lower Af...
Benzinga Newsdesk
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
Pooja Rajkumari
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
Rounak Jain
Thursday, November 14, 2024
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Michael Cohen
Donald Trump Jr. Posts On X "Robert F Kennedy...
Benzinga Newsdesk
Shares of vaccine stocks are trading lower fo...
Benzinga Newsdesk
'Trump Expected To Select Robert F. Kennedy J...
Benzinga Newsdesk
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Novavax...
Benzinga Newsdesk
Tuesday, November 12, 2024
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
Vandana Singh
Novavax shares are trading lower after the co...
Benzinga Newsdesk
Novavax Expects 2024 Total Revenues Of $650M-...
Benzinga Newsdesk
Novavax Q3 2024 GAAP EPS $(0.76) Beats $(0.83...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Novavax...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Earnings Outlook For Novavax
Benzinga Insights
Spotlight on Novavax: Analyzing the Surge in Options Activity
Benzinga Insights
Looking Into Novavax's Recent Short Interest
Benzinga Insights
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Vandana Singh
Novavax shares are trading higher after the F...
Benzinga Newsdesk
U.S. FDA Has Removed The Clinical Hold On No...
Benzinga Newsdesk
Wednesday, November 06, 2024
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
Vandana Singh
How Is The Market Feeling About Novavax?
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch